Patents by Inventor Monika Wroclawska

Monika Wroclawska has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF AN MDM2 INHIBITOR FOR THE TREATMENT OF MYELOFIBROSIS
    Publication number: 20220331318
    Abstract: The invention relates to the use of an MDM2 inhibitor in the treatment of myelofibrosis (MF). The invention also relates to a pharmaceutical combination comprising a) an MDM2 inhibitor and b) at least one further therapeutic agent, preferably ruxolitinib or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 14, 2020
    Publication date: October 20, 2022
    Inventors: Asa Eliasson, Nelson Guerreiro, Christophe Meille, Hans Menssen, K Gary J Vanasse, Monika Wroclawska
  • USE OF HIGH-AFFINITY, LIGAND-BLOCKING, HUMANIZED ANTI-T-CELL IMMUNOGLOBULIN DOMAIN AND MUCIN DOMAIN-3 (TIM-3) IGG4 ANTIBODY FOR THE TREATMENT OF MYELOFIBROSIS
    Publication number: 20220306737
    Abstract: The invention relates to the use of an anti-TIM-3 antibody molecule in the treatment of myelofibrosis (MF). The invention also relates to a pharmaceutical combination comprising a) an anti-TIM-3 antibody molecule and b) at least one further therapeutic agent, preferably ruxolitinib or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 14, 2020
    Publication date: September 29, 2022
    Inventors: Asa Eliasson, Hans Menssen, K Gary J Vanasse, Monika Wroclawska